Sven Wehrwein

Track

Insider profile

Currently holds positions in Proto Labs Inc, SPS Commerce Inc and AtriCure Inc

Performance

Overall performance
3.0
Performance over holding periods
3.0
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 54% 68% 82%
Transactions
47 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Chairman of the Board Proto Labs Inc May 1, 2017 -
Independent Director SPS Commerce Inc July 1, 2008 -
Independent Director AtriCure Inc Nov. 11, 2016 -
Lead Independent Director Proto Labs Inc June 1, 2011 - May 1, 2017
Independent Director Image Sensing Systems Inc Oct. 1, 2006 - May 18, 2012
Independent Director Synovis Life Technologies Inc Dec. 1, 2004 - Feb. 14, 2012
Sven Wehrwein's trades of AtriCure Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-28 2026-07-28
US AtriCure Inc (ATRC)
PrS Proposed sale
63,159
373.61
US$4,191,312 		63,159 373.61 US$4,191,312
2026-06-04 2026-06-02
S Sale
49,018 -47.5%
41.00
US$297,912 		49,018 -47.5% 41.00 US$297,912
2026-06-04 2026-06-02
S Sale
48,429 +8.0%
424.99
US$2,280,866 		48,429 +8.0% 424.99 US$2,280,866
2026-06-04 2026-06-02
S Sale
1,500 -4.3%
76.91
US$115,360 		1,500 -4.3% 76.91 US$115,360
2026-06-04 2026-06-02
S Sale
1,500 -4.3%
76.91
US$115,360 		1,500 -4.3% 76.91 US$115,360
2026-06-01 2026-06-01
PrS Proposed sale
2,000
75.95
US$151,900 		2,000 75.95 US$151,900
2025-11-26 2025-11-25
US AtriCure Inc (ATRC)
S Sale
4,967 -12.6%
38.00
US$188,746 		4,967 -12.6% 38.00 US$188,746
2025-11-25 2025-11-25
US AtriCure Inc (ATRC)
PrS Proposed sale
4,967
38.00
US$188,746 		4,967 38.00 US$188,746
2025-11-26 2025-11-24
US AtriCure Inc (ATRC)
S Sale
5,033 -12.8%
37.32
US$187,832 		5,033 -12.8% 37.32 US$187,832
2025-11-24 2025-11-24
US AtriCure Inc (ATRC)
PrS Proposed sale
5,033
37.32
US$187,854 		5,033 37.32 US$187,854
2025-08-26 2025-08-22
US AtriCure Inc (ATRC)
S Sale
5,000 -12.7%
37.00
US$185,000 		5,000 -12.7% 37.00 US$185,000
2025-08-22 2025-08-22
US AtriCure Inc (ATRC)
PrS Proposed sale
5,000
37.00
US$185,000 		5,000 37.00 US$185,000
2025-08-21 2025-08-19
US AtriCure Inc (ATRC)
S Sale
5,000 -12.7%
36.00
US$180,000 		5,000 -12.7% 36.00 US$180,000
2025-08-19 2025-08-19
US AtriCure Inc (ATRC)
PrS Proposed sale
5,000
36.00
US$180,000 		5,000 36.00 US$180,000
2024-08-13 2024-08-09
S Sale
542 -3.2%
202.63
US$109,825 		542 -3.2% 202.63 US$109,825
2024-08-13 2024-08-09
S Sale
400 -2.3%
202.14
US$80,855 		400 -2.3% 202.14 US$80,855
2024-08-13 2024-08-09
S Sale
1,058 -5.8%
200.40
US$212,024 		1,058 -5.8% 200.40 US$212,024
2024-08-09 2024-08-09
PrS Proposed sale
2,000
201.35
US$402,704 		2,000 201.35 US$402,704
2024-02-16 2024-02-15
S Sale
1,640 -9.4%
198.41
US$325,398 		1,640 -9.4% 198.41 US$325,398
2024-02-16 2024-02-15
S Sale
768 -4.2%
194.08
US$149,054 		768 -4.2% 194.08 US$149,054
2024-02-15 2024-02-15
PrS Proposed sale
2,408
197.03
US$474,452 		2,408 197.03 US$474,452
2024-02-16 2024-02-14
S Sale
400 -2.2%
195.71
US$78,286 		400 -2.2% 195.71 US$78,286
2024-02-16 2024-02-14
S Sale
842 -4.5%
194.88
US$164,088 		842 -4.5% 194.88 US$164,088
2024-02-16 2024-02-14
S Sale
800 -4.1%
193.64
US$154,915 		800 -4.1% 193.64 US$154,915
2024-02-16 2024-02-14
S Sale
958 -4.7%
192.22
US$184,146 		958 -4.7% 192.22 US$184,146
2024-02-14 2024-02-14
PrS Proposed sale
3,000
193.81
US$581,434 		3,000 193.81 US$581,434
2023-11-03 2023-11-02
S Sale
500 -2.8%
163.97
US$81,983 		500 -2.8% 163.97 US$81,983
2023-11-02 2023-11-02
PrS Proposed sale
500
163.97
US$81,983 		500 163.97 US$81,983
2023-11-03 2023-11-01
PrS Proposed sale
1,000
160.45
US$160,453 		1,000 160.45 US$160,453
2023-11-03 2023-11-01
S Sale
120 -0.7%
161.13
US$19,336 		120 -0.7% 161.13 US$19,336
2023-11-03 2023-11-01
S Sale
880 -4.8%
160.36
US$141,117 		880 -4.8% 160.36 US$141,117
2023-11-01 2023-11-01
PrS Proposed sale
1,000
160.45
US$160,453 		1,000 160.45 US$160,453
2023-08-15 2023-08-11
S Sale
1,000 -5.4%
170.03
US$170,028 		1,000 -5.4% 170.03 US$170,028
2023-08-02 2023-08-02
PrS Proposed sale
1,000
175.16
US$175,160 		1,000 175.16 US$175,160
2023-03-16 2023-03-14
S Sale
1,000 -5.4%
145.37
US$145,372 		1,000 -5.4% 145.37 US$145,372
2022-08-17 2022-08-15
S Sale
1,000 -5.4%
132.99
US$132,990 		1,000 -5.4% 132.99 US$132,990
2022-08-09 2022-08-05
S Sale
1,000 -5.4%
131.00
US$131,000 		1,000 -5.4% 131.00 US$131,000
2021-11-22 2021-11-18
S Sale
1,100 -6.1%
150.06
US$165,066 		1,100 -6.1% 150.06 US$165,066
2021-11-18 2021-11-17
S Sale
900 -5.1%
150.13
US$135,116 		900 -5.1% 150.13 US$135,116
2021-11-18 2021-11-16
S Sale
2,362 -12.3%
149.29
US$352,633 		2,362 -12.3% 149.29 US$352,633
2021-05-05 2021-05-03
US AtriCure Inc (ATRC)
S Sale
5,000 -28.3%
78.19
US$390,950 		5,000 -28.3% 78.19 US$390,950
2021-05-05 2021-05-03
US AtriCure Inc (ATRC)
S Sale
5,000 -28.3%
77.75
US$388,750 		5,000 -28.3% 77.75 US$388,750
2021-02-22 2021-02-19
S Sale
5,752 -26.6%
110.23
US$634,054 		5,752 -26.6% 110.23 US$634,054
2021-02-22 2021-02-18
S Sale
300 -1.9%
110.05
US$33,015 		300 -1.9% 110.05 US$33,015
2020-11-20 2020-11-19
S Sale
3,000 -15.9%
94.18
US$282,542 		3,000 -15.9% 94.18 US$282,542